MADISON, Wis., Sept. 28, 2016 /PRNewswire/ -- Exact
Sciences Corp. (Nasdaq: EXAS) today announced that the company will
host a webcast and conference call on Oct.
26, 2016, to discuss its third-quarter 2016 financial
results.
Third-Quarter 2016 Webcast and Conference Call
Details
Date:
|
Wednesday, Oct. 26,
2016
|
Time:
|
10 a.m. ET, 9 a.m.
CT
|
Webcast:
|
The live webcast can
be accessed at www.exactsciences.com
|
Telephone:
|
Domestic callers,
dial
877-201-0168
|
|
International
callers, dial 647-788-4901
|
|
Access code for both
domestic and international callers: 90495271
|
An archive of the webcast will be available at
www.exactsciences.com. A replay of the conference call will
be available by calling 855-859-2056 domestically or 404-537-3406
internationally. The access code for the replay is 90495271.
The webcast, conference call and replay are open to all interested
parties.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused
on the early detection and prevention of some of the deadliest
forms of cancer. The company has exclusive intellectual property
protecting its noninvasive, molecular screening technology for the
detection of colorectal cancer. Cologuard is included in the
colorectal cancer screening guidelines of the American Cancer
Society and stool DNA is included in the guidelines of the U.S.
Multi-Society Task Force on Colorectal Cancer. For more
information, please follow us on Twitter @ExactSciences or find us
on Facebook.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of
1934, as amended, that are intended to be covered by the "safe
harbor" created by those sections. Forward-looking
statements, which are based on certain assumptions and describe our
future plans, strategies and expectations, can generally be
identified by the use of forward-looking terms such as "believe,"
"expect," "may," "will," "should," "could," "seek," "intend,"
"plan," "estimate," "anticipate" or other comparable terms.
All statements other than statements of historical facts included
in this news release regarding our strategies, prospects, financial
condition, operations, costs, plans and objectives are
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding expected future
operating results, anticipated results of our sales and marketing
efforts, expectations concerning payor reimbursement and the
anticipated results of our product development efforts.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, projections,
anticipated events and trends, the economy and other future
conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of
which are outside of our control. Our actual results and financial
condition may differ materially from those indicated in the
forward-looking statements. Therefore, you should not rely on any
of these forward-looking statements. Important factors that could
cause our actual results and financial condition to differ
materially from those indicated in the forward-looking statements
include, among others, the following: our ability to successfully
and profitably market our products and services; the acceptance of
our products and services by patients and healthcare providers; the
willingness of health insurance companies and other payors to cover
Cologuard and reimburse us for our performance of the Cologuard
test; the amount and nature of competition from other cancer
screening products and services; the effects of any healthcare
reforms, including the Affordable Care Act, or changes in
healthcare pricing, coverage and reimbursement; recommendations,
guidelines and quality metrics issued by various organizations such
as the U.S. Preventive Services Task Force, the American Cancer
Society, and the National Committee for Quality Assurance regarding
cancer screening or our products and services; our ability to
successfully develop new products and services; our success
establishing and maintaining collaborative, licensing and supplier
arrangements; our ability to maintain regulatory approvals and
comply with applicable regulations; and the other risks and
uncertainties described in the Risk Factors and in Management's
Discussion and Analysis of Financial Condition and Results of
Operations sections of our most recently filed Annual Report on
Form 10-K and our subsequently filed Quarterly Report(s) on Form
10-Q. We undertake no obligation to publicly update any
forward-looking statement, whether written or oral, that may be
made from time to time, whether as a result of new information,
future developments or otherwise.
Contact:
J.P.
Fielder
Senior Director, Corporate Communications, Exact Sciences Corp.
608-210-5220
jpfielder@exactsciences.com
Logo - http://photos.prnewswire.com/prnh/20160108/320353
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/exact-sciences-to-host-third-quarter-2016-results-webcast-and-call-300335387.html
SOURCE EXACT SCIENCES CORP